Protagonist Therapeutics (PTGX) Q2 2024 Earnings

8MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.7
0.66
2.01
3.37

Details

Expected EPS
3.366667
Actual EPS
3.26
Surprise EPS
-0.11
Surprise Percent
+3.17%

Description

Protagonist Therapeutics (PTGX) has reported earnings of 3.26 per share for Q2 2024.

0 Comments

Share your thoughts